Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Shigeki Momohara »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Shigeki Makino < Shigeki Momohara < Shigeki Nakamura  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000630 (2018) Hitoshi Imamura [Japon] ; Shigeki Momohara [Japon] ; Koichiro Yano [Japon] ; Yu Sakuma [Japon] ; Masanori Nakayama [Japon] ; Haruki Tobimatsu [Japon] ; Katsunori Ikari [Japon]Tocilizumab treatment in patients with rheumatoid arthritis is associated with reduced fibrinogen levels and increased blood loss after total knee arthroplasty.
000723 (2018) Yoko Shimizu [Japon] ; Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Kumi Shidara [Japon] ; Naoki Sugimoto [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.
000A94 (2017) Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Rei Yamaguchi [Japon] ; Yoko Shimizu [Japon] ; Akiko Kobayashi [Japon] ; Naoki Sugimoto [Japon] ; Daisuke Hoshi [Japon] ; Kumi Shidara [Japon] ; Eri Sato [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
001155 (2015) Eiichi Tanaka [Japon] ; Eisuke Inoue ; Daisuke Hoshi ; Yoko Shimizu ; Akiko Kobayashi ; Naoki Sugimoto ; Kumi Shidara ; Eri Sato ; Yohei Seto ; Ayako Nakajima ; Shigeki Momohara ; Atsuo Taniguchi ; Hisashi YamanakaCost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
001173 (2015) Eri Sato [Japon] ; Eiichi Tanaka ; Moeko Ochiai ; Yoko Shimizu ; Akiko Kobayashi ; Kumi Shidara ; Daisuke Hoshi ; Naoki Sugimoto ; Eisuke Inoue ; Yohei Seto ; Ayako Nakajima ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi YamanakaChronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
001597 (2013) Daisuke Hoshi [Japon] ; Ayako Nakajima ; Kumi Shidara ; Yohei Seto ; Eiichi Tanaka ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi YamanakaDisability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.
001626 (2013) Shigeki Momohara [Japon] ; Jun Hashimoto ; Hideki Tsuboi ; Hisaaki Miyahara ; Natsuko Nakagawa ; Atsushi Kaneko ; Naoki Kondo ; Hiroaki Matsuno ; Takahiko Wada ; Tohgo Nonaka ; Katsuaki Kanbe ; Haruki Takagi ; Akira Murasawa ; Tsukasa Matsubara ; Toru SuguroAnalysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.
001758 (2012) Daisuke Hoshi [Japon] ; Ayako Nakajima ; Eisuke Inoue ; Kumi Shidara ; Eri Sato ; Mariko Kitahama ; Yohei Seto ; Eiichi Tanaka ; Wako Urano ; Naomi Ichikawa ; Yumi Koseki ; Shigeki Momohara ; Astuo Taniguchi ; Norihiro Nishimoto ; Hisashi YamanakaIncidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.
001914 (2011) Hisashi Yamanaka [Japon] ; Yoshiya Tanaka ; Eisuke Inoue ; Daisuke Hoshi ; Shigeki Momohara ; Kentaro Hanami ; Naoki Yunoue ; Kazuyoshi Saito ; Kouichi Amano ; Hideto Kameda ; Tsutomu TakeuchiEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
001943 (2011) Ryo Hiroshima [Japon] ; Kosei Kawakami ; Takuji Iwamoto ; Asami Tokita ; Koichiro Yano ; Yu Sakuma ; Katsunori Ikari ; Shigeki MomoharaAnalysis of C-reactive protein levels and febrile tendency after joint surgery in rheumatoid arthritis patients treated with a perioperative 4-week interruption of tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Shigeki Momohara" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Shigeki Momohara" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Shigeki Momohara
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021